Treatment of 320 genotype 3 cirrhotic patients with 12 weeks Sofosbuvir/Velpatasvir with or without ribavirin: real life experience from Italy. (February 2019) - Pasulo, L.; Gambato, M.; Spinetti, A.; D'Ambrosio, R.; Puoti, M.; Ciancio, A.; Di Marco, V.; Calvaruso, V.; Colombatto, P.; Brunetto, M.; Schiavini, M.; Fabris, P.; et al.